Stiripentol: Efficacy and Tolerability in Children with Epilepsy

1999149 citationsJournal Articlebronze Open Access

Authors

Joëlle Perez · Inserm

Catherine Chiron · Hôpital Saint-Vincent-de-Paul

C. Musial · Hôpital Saint-Vincent-de-Paul

Elisabeth Rey · Hôpital Saint-Vincent-de-Paul

Henri Bléhaut · Hôpital Saint-Vincent-de-Paul

P D’Athis · Hôpital Saint-Vincent-de-Paul

Jean‐Louis Vincent ·

Abstract

STP seems to be a promising add-on drug, particularly when combined with CBZ in patients with partial childhood epilepsy refractory to vigabatrin (VGB) and with CLB in patients with severe myoclonic epilepsy in infancy.

Topics & Keywords

Epilepsy research and treatment Pharmacological Effects and Toxicity Studies Metabolism and Genetic Disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Epilepsia

Volume 40, Issue 11, pp. 1618-1626

DOI: 10.1111/j.1528-1157.1999.tb02048.x

Field-Weighted Citation Impact: 1.41